The Potential Risk of Povidone-Iodine in Sperm Quality: A Case Report
Journal of Drugs in Dermatology : JDD
|March 5, 2025
Summary
Topical povidone-iodine (PVP-I) therapy may negatively impact male fertility. Long-term use in one patient led to severe declines in sperm quality, including concentration, motility, and morphology, highlighting potential risks for men undergoing fertility treatments.
Area of Science:
- Reproductive Medicine
- Dermatology
- Toxicology
Background:
- Male infertility is a significant concern, impacting a substantial portion of couples seeking assisted reproductive technologies.
- Secondary infertility, developing after a period of fertility, can have various underlying causes.
- Topical treatments for dermatological conditions are common, but their systemic effects require careful consideration, especially in patients with fertility concerns.
Purpose of the Study:
- To document a rare case of severe oligoasthenoteratozoospermia potentially linked to prolonged topical povidone-iodine (PVP-I) application.
- To raise awareness among healthcare providers and patients about the potential adverse effects of PVP-I on sperm parameters.
- To emphasize the importance of considering all therapeutic agents, including topical ones, when evaluating male infertility.
Main Methods:
- Case report of a 45-year-old male patient with secondary infertility.
- Sperm analysis (SA) performed before and after a three-month period of topical PVP-I liniment use for fungal infection.
- Follow-up SA conducted after 77 days of PVP-I discontinuation to assess recovery of sperm parameters.
Main Results:
- Initial SA revealed mild asthenospermia; however, after three months of topical PVP-I use, repeat SA showed severe oligoasthenoteratozoospermia (low sperm count, poor motility, abnormal morphology).
- Following cessation of PVP-I therapy, sperm concentration and normal morphology gradually normalized.
- Sperm motility showed only partial recovery, suggesting a potentially lasting impact on this parameter.
Conclusions:
- Long-term topical povidone-iodine (PVP-I) therapy may be associated with a decline in sperm quality, affecting count, motility, and morphology.
- While the precise mechanism remains unclear, the findings suggest PVP-I could act as a spermatotoxin.
- Men undergoing fertility treatments should be informed about the potential risks of topical PVP-I use on reproductive health, prompting further investigation into this adverse effect.
Related Concept Videos
Spermatogenesis
102.0K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.0K
Hand hygiene
3.1K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
3.1K
Infertility in Males
228
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
228
Surface Membrane Barriers
843
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
843
Oogenesis
63.3K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.3K
Birth Control Methods
154
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
154


